Individualising clinical advice is key! In this webinar on NK receptor blockers, we talked about what they do, how they work, the benefits, side effects/risks, monitoring requirements and what data to expect from future trials.

These agents add to the various lifestyle interventions, non-hormonal and alternative therapies and hormone replacement therapy (HRT) options for menopause symptom treatment. All these options have their unique roles, indications and in the case of medications - benefits & risks.

Fezolinetant and Elinzanetant are the two to have completed recent clinical trials and Fezolinetant has already been licensed for use in the UK. More trials are planned or on going.

No one size fits all and more the options, better it is for individuals to choose from and stick to what works for them. Let’s all continue to campaign and work together to improve health of women post-menopause.

Robust scientific evidence is not based on cherry picking favourable reports or prescribing based on assumptions, personal experience or popular opinion. Where there is no evidence, it needs to be acknowledged so that patients can decide their options and make a choice.

Healthcare professionals need reliable evidence based information and resources such as ‘time to listen’ and logistic support (to regularly review and follow-up during the transition) so that they can discuss various menopause interventions (their individual pros and cons).

As said before, there are lifestyle and non-hormonal options (depending on the type of symptoms) which aim to improve quality of life and protect long-term health post menopause. Women should be offered a choice of all options and provided with accurate information.

Not all women need or wish to take HRT (and for some, it may be contraindicated) but it should not be denied to individuals who wish to take it and where benefits outweigh risks. HRT has benefits, can cause side effects for some individuals and has associated long term risks.

Hormone replacement therapy (systemic or local) is a medication. It remains the most effective medical treatment for menopausal vasomotor and genitourinary symptoms.

Healthy lifestyle remains the most important factor in protecting long term health. Many women prefer non-HRT options or therapies to address symptoms and long term health. Others decide to take HRT when its benefits outweigh risks for them.

Depending on genetics, background health and life style choices - menopause transition can have a variable impact on long-term health (bone, heart, brain and metabolic). Every one chooses to approach and manage menopause in their unique way.

RT @ESHRE_IRHEC: 📊 How successful is IVF? Many people think it’s much more successful than it is. IVF can be a complex process & while it…

Let's come together to encourage and inspire everyone to strive hard for progress in Women’s Health and overcome the existing barriers and challenges. Thank you @BasselWattar for making this happen!

We will touching on topics involving hormone journey during the entire life course ranging from menstrual health, fibroids, fertility, miscarriage, pregnancy to perimenopause and menopause.

Thank you for sharing 🙏

There is a need for more research into sexual dysfunction in young people with endocrine conditions as the current available evidence about prevalence rates and efficacy of treatments is limited.

Management of sexual dysfunction therefore often requires a multidisciplinary approach targeting physical and psychological components.